NCT03166696|Unknown
Acute Myocardial Infarction and Acute Cerebral Infarction (AMIAC) Registry and Follow-up
AMIAC
The Registry and Follow-up of Patients With Acute Myocardial Infarction or Acute Cerebral Infarction
Loading search results
AMIAC
The Registry and Follow-up of Patients With Acute Myocardial Infarction or Acute Cerebral Infarction
Sponsor study identifier
observational
30,000
1 country
3
Study Start
January 3, 2000
Actual (reported)Primary Completion
May 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
A registry of consecutive patients who were admitted and diagnosed with acute myocardial infarction or acute cerebral infarction were conducted at the Guangdong General Hospital or the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Yue Bei People's Hospital, China, between January 2000 and December 2016. The adverse clinical outcomes, including all-cause mortality, were followed from the date of admission for acute myocardial infarction or acute cerebral infarction until study end (December 31, 2016). All-cause mortality, including the date of death, was identified from the electronic hospitalization data, phone follow-up, and confirmed by the household registration (HUKOU) system, a record of registration required by law in China. Baseline characteristics, including major treatment of acute myocardial infarction or acute cerebral infarction, estimated glomerular filtration rate (eGFR) and proteinuria, were collected. Demographic data were determined from the electronic hospitalization data and electronic hospital discharge records. All comorbid conditions were identified using International Statistical Classification of Diseases, Tenth Revision (ICD-10), coding algorithms applied to electronic physician claims and electronic hospital discharge records. Life style (smoking), treatment regimen at discharge, including angiotensin-converting enzyme inhibitor (ACEI), angiotensin II receptor blocker (ARB), were determined from the electronic hospitalization data.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 3, 2000
Actual (reported)May 18, 2017
Actual (reported)May 25, 2017
Actual (reported)May 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
May 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
all-cause mortality
all-cause mortality
follow up until the study end (May 2018,Anticipated)
kidney outcome
follow up until the study end (May 2018,Anticipated)
the registry and follow up of consecutive patients who were admitted and diagnosed with acute cerebral infarction
the registry and follow up of consecutive patients who were admitted and diagnosed with acute myocardial infarction
the consecutive patients who were admitted and diagnosed with acute myocardial infarction or acute cerebral infarction at the Guangdong General Hospital or the First Affiliated Hospital of Guangzhou University of Chinese Medicine, Yue Bei People's Hospital, China, between January 2000 and December 2016.
Guangdong General Hospital
Guangzhou, Guangdong, 510080, China
the First Affiliated Hospital of Guangzhou University of Chinese Medicine
Guangzhou, Guangdong, 510405, China
Yue Bei People's Hospital
Shaoguan, Guangdong, 512025, China
Liming Yao, M.D.
Guangdong Provincial People's Hospital
First Submitted
May 18, 2017
First Posted
May 25, 2017
Study Start
January 3, 2000
Actual (reported)Primary Completion
May 2018
Estimated (date passed)Simplified Rapid Hydration in Preventing CA-AKI Among Patients With Chronic Kidney Disease
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
May 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 25, 2017
Record last verified: 2017-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: